Lymphoma News

Treating lymphoma today starts with an understanding of what is being treated, and the revolution in genetic profiling lets clinicians do that with more precision than ever.

A toxin linked to a targeted monoclonal antibody has shown "compelling" antitumor activity in patients with non-Hodgkin lymphomas who were no longer responding to treatment, according to a report from Dana-Farber Cancer Institute.

A Bradford dad has died before fundraising friends could get him potentially life-saving treatment which is not available on the NHS .

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited today announced updated overall survival data from two ADCETRIS pivotal Phase 2 clinical trials in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large cell lymphoma were presented at the 55th American Society of Hematology Annual Meeting and ... (more)

Andre Goy, M.D., Chairman and Director, and Chief of Lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates, presented new data providing further insight into the complexity of the genomic landscape in high-risk diffuse large B-cell lymphoma , the most common subtype ... (more)

The woman I call my wife and I aren't married. Blame it on procrastination and the fact that we both had bitter divorces.

MAYWOOD, Il. - Donated umbilical cord blood contains stem cells that can save the lives of patients with leukemia, lymphoma and other blood cancers.

Mike Wallis's wife Rachel died aged 31, after a fight which saw her diagnosed for cancer three times.

Valerie Esposito of Everett on Saturday held up her phone with a photo of her as a young child with Globe Santa.

The legal endeavor to force an 11-year-old Amish girl with cancer to undergo chemotherapy against her wishes was concluded on Friday when the court-appointed guardian dropped the matter.

Two patients who researchers hoped had been cured of HIV have seen their infections return, dashing hopes that the virus had been eradicated from their bodies.

Doctors have been reporting "unprecedented success" in using gene therapy to transform the blood cells of patients blood cells into soldiers that seek and destroy leukemia.

After being declared HIV -free following a dangerous bone marrow transplant procedure earlier this summer, a pair of Boston-area men are now apparently showing traces of the virus in their blood once again.

Kite Pharma's Lead Program with the National Cancer Institute Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma Kite Pharma's Lead Program with the National Cancer Institute Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma /PRNewswire/ -- Kite Pharma, Inc. , a clinical-stage ... (more)

Infinity Pharmaceuticals today announced updated Phase 1 data from an ongoing study of IPI-145, its oral inhibitor of phosphoinositide-3-kinase -delta and PI3K-gamma, in patients with relapsed/refractory indolent non-Hodgkin lymphoma , a potentially fatal hematologic malignancy .

State Sen. Mike Folmer, R-Lebanon, was diagnosed with non-Hodgkin's lymphoma in early 2012.

Sequenta, Inc. today announced that researchers from the National Cancer Institute will present data showing that in the first five years post-treatment, the company's sequencing-based minimal residual disease assay can detect relapse of diffuse large B-cell lymphoma a median of 7.4 months prior to when the disease is detected via CT scan.

Once you're logged in, at the top of each article, video or slideshow you will see a list of your Facebook friends who recently visited Choose to share stories you'e read with your friends or turn sharing OFF to keep your reading experience anonymous .

In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy cancer.

FoundationOne Heme, Foundation Medicine's Second Clinical Product, is a Fully Informative Genomic Profile for Hematologic Malignancies, Sarcomas and Pediatric Cancers )-- Foundation Medicine announced today the launch of its second clinical product, FoundationOnea Heme, a fully informative genomic profile for hematologic cancers , as well as many ... (more)